Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEPW) Debt to Equity (2021 - 2025)

Coeptis Therapeutics Holdings has reported Debt to Equity over the past 5 years, most recently at $0.01 for Q4 2025.

  • Quarterly results put Debt to Equity at $0.01 for Q4 2025, down 96.97% from a year ago — trailing twelve months through Dec 2025 was $0.01 (down 96.97% YoY), and the annual figure for FY2025 was $0.01, down 96.97%.
  • Debt to Equity for Q4 2025 was $0.01 at Coeptis Therapeutics Holdings, down from $0.01 in the prior quarter.
  • Over the last five years, Debt to Equity for COEPW hit a ceiling of $0.7 in Q4 2021 and a floor of -$0.48 in Q2 2024.
  • Median Debt to Equity over the past 5 years was $0.06 (2023), compared with a mean of $0.08.
  • Biggest five-year swings in Debt to Equity: soared 447.12% in 2023 and later tumbled 732.28% in 2024.
  • Coeptis Therapeutics Holdings' Debt to Equity stood at $0.7 in 2021, then crashed by 95.2% to $0.03 in 2022, then soared by 447.12% to $0.18 in 2023, then skyrocketed by 91.17% to $0.35 in 2024, then tumbled by 96.97% to $0.01 in 2025.
  • The last three reported values for Debt to Equity were $0.01 (Q4 2025), $0.01 (Q3 2025), and $0.02 (Q2 2025) per Business Quant data.